Review Topical Sections

Smart systems related to polypeptide sequences

  • Received: 29 December 2015 Accepted: 03 March 2016 Published: 09 March 2016
  • Increasing interest for the application of polypeptide-based smart systems in the biomedical field has developed due to the advantages given by the peptidic sequence. This is due to characteristics of these systems, which include: biocompatibility, potential control of degradation, capability to provide a rich repertoire of biologically specific interactions, feasibility to self-assemble, possibility to combine different functionalities, and capability to give an environmentally responsive behavior. Recently, applications concerning the development of these systems are receiving greater attention since a targeted and programmable release of drugs (e.g. anti-cancer agents) can be achieved. Block copolymers are discussed due to their capability to render differently assembled architectures. Hybrid systems based on silica nanoparticles are also discussed. In both cases, the selected systems must be able to undergo fast changes in properties like solubility, shape, and dissociation or swelling capabilities. This review is structured in different chapters which explain the most recent advances on smart systems depending on the stimuli to which they are sensitive. Amphiphilic block copolymers based on polyanionic or polycationic peptides are, for example, typically employed for obtaining pH-responsive systems. Elastin-like polypeptides are usually used as thermoresponsive polymers, but performance can be increased by using techniques which utilize layer-by-layer electrostatic self-assembly. This approach offers a great potential to create multilayered systems, including nanocapsules, with different functionality. Recent strategies developed to get redox-, magnetic-, ultrasound-, enzyme-, light- and electric-responsive systems are extensively discussed. Finally, some indications concerning the possibilities of multi-responsive systems are discussed.

    Citation: Lourdes Franco, Luís J. del Valle, Jordi Puiggalí. Smart systems related to polypeptide sequences[J]. AIMS Materials Science, 2016, 3(1): 289-323. doi: 10.3934/matersci.2016.1.289

    Related Papers:

    [1] Fang Liu, Yanfei Du . Spatiotemporal dynamics of a diffusive predator-prey model with delay and Allee effect in predator. Mathematical Biosciences and Engineering, 2023, 20(11): 19372-19400. doi: 10.3934/mbe.2023857
    [2] Honghua Bin, Daifeng Duan, Junjie Wei . Bifurcation analysis of a reaction-diffusion-advection predator-prey system with delay. Mathematical Biosciences and Engineering, 2023, 20(7): 12194-12210. doi: 10.3934/mbe.2023543
    [3] Meiling Zhu, Huijun Xu . Dynamics of a delayed reaction-diffusion predator-prey model with the effect of the toxins. Mathematical Biosciences and Engineering, 2023, 20(4): 6894-6911. doi: 10.3934/mbe.2023297
    [4] Guangxun Sun, Binxiang Dai . Stability and bifurcation of a delayed diffusive predator-prey system with food-limited and nonlinear harvesting. Mathematical Biosciences and Engineering, 2020, 17(4): 3520-3552. doi: 10.3934/mbe.2020199
    [5] Shunyi Li . Hopf bifurcation, stability switches and chaos in a prey-predator system with three stage structure and two time delays. Mathematical Biosciences and Engineering, 2019, 16(6): 6934-6961. doi: 10.3934/mbe.2019348
    [6] Kawkab Al Amri, Qamar J. A Khan, David Greenhalgh . Combined impact of fear and Allee effect in predator-prey interaction models on their growth. Mathematical Biosciences and Engineering, 2024, 21(10): 7211-7252. doi: 10.3934/mbe.2024319
    [7] Kalyan Manna, Malay Banerjee . Stability of Hopf-bifurcating limit cycles in a diffusion-driven prey-predator system with Allee effect and time delay. Mathematical Biosciences and Engineering, 2019, 16(4): 2411-2446. doi: 10.3934/mbe.2019121
    [8] Xin-You Meng, Yu-Qian Wu . Bifurcation analysis in a singular Beddington-DeAngelis predator-prey model with two delays and nonlinear predator harvesting. Mathematical Biosciences and Engineering, 2019, 16(4): 2668-2696. doi: 10.3934/mbe.2019133
    [9] Yue Xing, Weihua Jiang, Xun Cao . Multi-stable and spatiotemporal staggered patterns in a predator-prey model with predator-taxis and delay. Mathematical Biosciences and Engineering, 2023, 20(10): 18413-18444. doi: 10.3934/mbe.2023818
    [10] Ting Yu, Qinglong Wang, Shuqi Zhai . Exploration on dynamics in a ratio-dependent predator-prey bioeconomic model with time delay and additional food supply. Mathematical Biosciences and Engineering, 2023, 20(8): 15094-15119. doi: 10.3934/mbe.2023676
  • Increasing interest for the application of polypeptide-based smart systems in the biomedical field has developed due to the advantages given by the peptidic sequence. This is due to characteristics of these systems, which include: biocompatibility, potential control of degradation, capability to provide a rich repertoire of biologically specific interactions, feasibility to self-assemble, possibility to combine different functionalities, and capability to give an environmentally responsive behavior. Recently, applications concerning the development of these systems are receiving greater attention since a targeted and programmable release of drugs (e.g. anti-cancer agents) can be achieved. Block copolymers are discussed due to their capability to render differently assembled architectures. Hybrid systems based on silica nanoparticles are also discussed. In both cases, the selected systems must be able to undergo fast changes in properties like solubility, shape, and dissociation or swelling capabilities. This review is structured in different chapters which explain the most recent advances on smart systems depending on the stimuli to which they are sensitive. Amphiphilic block copolymers based on polyanionic or polycationic peptides are, for example, typically employed for obtaining pH-responsive systems. Elastin-like polypeptides are usually used as thermoresponsive polymers, but performance can be increased by using techniques which utilize layer-by-layer electrostatic self-assembly. This approach offers a great potential to create multilayered systems, including nanocapsules, with different functionality. Recent strategies developed to get redox-, magnetic-, ultrasound-, enzyme-, light- and electric-responsive systems are extensively discussed. Finally, some indications concerning the possibilities of multi-responsive systems are discussed.


    1. Introduction

    In ecological systems, the interactions between different species can generate rich phenomena. Many models are derived to illustrate the predator-prey system from the view of both mathematics and biology [2,22,28,32]. Meanwhile, it is well known that the spatial structure may further affect the population dynamics of the species [7,8,15]. The spatially homogeneous reaction-diffusion predator-prey model with classical Lotka-Volterra interaction and no flux boundary conditions has been studied by many scholars, and the unique positive steady state solution is globally asymptotically stable in that case [21]. Our work is based on the important contribution of Yi, Wei and Shi [35] in the bifurcation analysis from the constant coexistence equilibrium solution of the following Rosenzweig-MacArthur model with Holling type-Ⅱ functional response [14,27]:

    $(BP) {Utd1ΔU=r1U(1UK)m1UVγ+U,xΩ, t>0,Vtd2ΔU=r2V+m2UVγ+U,xΩ, t>0,νU=νV=0,xΩ, t>0.U(x,0)=U0(x)0,   V(x,0)=V0(x)0,xΩ.
    $

    Here $U=U(x,t)$, ~$V=V(x,t)$ stand for the densities of the prey and predator at time $t>0$, and a spatial position $x\in\Omega$, respectively; $\Omega$ is a bounded domain in $\mathbb{R}^n$ with a smooth boundary $\partial{\Omega}$; $\nu$ is the outward unit normal vector on $\partial{\Omega}$, and no flux boundary condition is imposed, so the system is a closed one. $d_{1},d_{2}>0$ are the diffusion coefficients of the species, and $r_{1},~r_{2},~m_{1},~m_{2},~K$ are positive real constants; the prey population follows a logistic growth, $r_{1}$ is the intrinsic growth rate of $U$, and $K$ is the carrying capacity; $r_{2}$ is the mortality rate of the predator in the absence of prey; $m_{1}$ is the search efficiency of $V$ for $U$ and $m_{2}$ represent the conversion rate of prey to predator; the function $\frac{U}{\gamma+K}$ denotes the functional response of the predator to the prey density changes. The parameter $\gamma(>0)$ is the half saturation constant which measures the "saturation" effect: the consumption of prey by a unit number of predators cannot continue to grow linearly with the number of prey available but must saturate at the value $\frac{1}{\gamma}$ [12,14]. After Yi et al., the method of Hopf bifurcation analysis has been extensively applied in reaction-diffusion equation, see [3,36].

    It is worth noting that the functional responses in two species are the same in the model $(BP)$ since the principle of energy conversion, and the only difference is that the coefficients are different. In fact, it is not always true in real ecological environment: energy can be converted or wasted. Motivated by this idea, we consider an interesting but serious interaction between the prey and predator from the view of wastage of energy. Biologists call this interaction "surplus killing"[20,31]. It is a common behavior exhibited by predators, in which they kill more prey than they can immediately eat and then cache or abandon the remainder [19].

    The term was invented by Dutch biologist Hans Kruuk [16] after studying spotted hyenas in Africa and red foxes in England. Other than humans, surplus killing has been observed among zooplankton, weasels, honey badgers, wolves, red foxes, leopards, lions, spotted hyenas, spiders[1,5,9,11,17,19,20,31]. The emergence of these phenomena refers to the fact that animals may only partially consume or abandon intact prey they have captured. There are many documented examples of predators exhibiting surplus killing. For example, Samu and Bíró [30] have found that the wandering spider, Pardosa hortensis (Lycosidae), exhibited significant levels of both partial feeding and prey abandonment at high rates of encounter with prey. In Canada's Northwest Territories, the researchers once found the bodies of 34 neonatal caribou calves that had been killed by wolves and scattered-some half-eaten and some completely untouched-over 3 square kilometres. In surplus killing, predators eat only the most-preferred animals and animal parts. Bears engaging in surplus killing of salmon are likelier to eat unspawned fish because of their higher muscle quality, and high-energy parts such as brains and eggs [16]. Surplus killing can deplete the overall food supply, waste predator energy and risk them being injured. Nonetheless, researchers say animals surplus kill whenever they can, in order to procure food for offspring and others, to gain valuable killing experience, and to create the opportunity to eat the carcass later when they are hungry again.

    Inspired by their work, in this article, we would like to study the following predator-prey system with the predator exhibiting a "surplus killing" behaviour which can be demonstrated by different functional responses in the equations.

    $ {utd1Δu=r1u(1uK1)m1uv,  xΩ, t>0,vtd2Δv=r2v(1vK2)+m2uvγ+u,  xΩ, t>0,uν =uν =0,  xΩ, t>0,u(x,0)=u0(x)0(0),  v(x,0)=v0(x)0(0),       xΩ.
    $
    (1)

    Here $r_{1},r_{2}$ is the intrinsic growth rate of $u,v$, respectively; $K_1,K_2$ is the corresponding carrying capacity of $u,v$; $m_{1}$ is the predation rate, and $m_2$ is the consumption rate with $m_2=\alpha m_1$ where $\alpha$ is a positive constant; the Holling Ⅰ type functional response $m_1u$ and the Holling Ⅱ type functional response $\frac{ m_2 u}{\gamma+u}$ show the " surplus killing" effect: the predators keep hunting whenever they find a potential targets, but the conversion is limited since most of the prey they have captured are abandoned.

    With a dimensionless change of variables:

    $ \tilde{u}=\cfrac{u}{\gamma},~~\tilde{v}=\cfrac{v}{K_2},~~\tilde{t}=r_1 t,~~\tilde{d_1}=\cfrac{d_1}{r_1},~~\tilde{d_2}=\cfrac{d_2}{r_1},\\ $
    $ ~~\theta=\cfrac{r_2}{r_1},~\widetilde{\gamma}=\cfrac{\gamma}{K_1},~~\widetilde{m}_1=\cfrac{m_1K_2}{r_1},~~\widetilde{m}_2=\cfrac{ m_2}{r_1}, $

    still denote $\tilde{u}$, $\tilde{v}$, $\tilde{t}$, $\widetilde{d}_1$, $\widetilde{d}_2$, $\widetilde{\gamma}$, $\widetilde{m}_1$, $\widetilde{m}_2$ by $u$, $v$, $t$, $d_1$, $d_2$, $\gamma$, $m_1$, $m_2$, then we obtain

    $ {utd1Δu=u(1γu)m1uv,xΩ, t>0,vtd2Δv=θv(1v)+m2uv1+u,xΩ, t>0,uν = uν =0,xΩ, t>0.u(x,0)=u0(x)0(0),   v(x,0)=v0(x)0(0),xΩ.
    $
    (2)

    Considering that the biomass that predator consumed cannot convert into the new production for an instant, we add time delay into the functional response of the second equation of (2), and make it conform with natural situation:

    $ {u(x,t)td1Δu(x,t)=u(x,t)(1γu(x,t))m1u(x,t)v(x,t),  xΩ, t>0,v(x,t)td2Δv(x,t)=θv(x,t)(1v(x,t))+m2u(x,tτ)v(x,t)1+u(x,tτ),  xΩ, t>0,uν=uν =0,    xΩ, t>0,u(x,t)=u0(x,t)0(0), v(x,t)=v0(x,t)0(0),  xΩ, τt0.
    $
    (3)

    Here, $d_1$, $d_2$, $\theta$, $\gamma$, $m_1$ and $m_2$ are all positive constants, and given that the predators in nature don't usually just eat one species, mostly they have other choices. Based on this, we turn the growth of $v$ into a logistic form which means $u$ is not the only hunting target for the predators, they can still live even though the prey $u$ became extinct.

    Define the real-valued Sobolev space

    $ X:=\{(u,v)\in H^{2}(0,l\pi)\times H^{2}(0,l\pi)|u_{x}=v_{x}=0,x=0,l\pi\}, $

    with inner product $\langle\cdot,\cdot\rangle$.

    For sake of discussion, we make the following assumption:

    $\left( {H1} \right){m_1} < 1.$

    The system (3) always has three non-negative constant equilibrium solutions: $E_0(0,0)$, $E_1(0,1)$, $E_2(1/\gamma,0)$, meanwhile, under the condition $(H1)$, the system also has a positive equilibrium $E_*(u_*,v_*)$, where

    $u=12γθ[Γ+Γ24γθ2(m11)],v=1m1(1γu).
    $

    with $\Gamma=\theta\gamma-\theta+\theta m_1+m_1 m_2$.

    Our main contribution for this article is a detailed and rigorous analysis about the global dynamics of the positive equilibrium of the diffusive predator-prey system (2). Keeping other parameters constant, we use the predation rate $m_1$ as a variable, and find that different values of $m_1$ result in distinct tendencies of the two species. Because of the effect of "surplus killing", the prey must raise their fertility rate or reduce the chances of encountering a predator to avoid extinction. For system (3), we shall be employing $\tau$ as our bifurcation parameter in our stability analyses to follow. When the spatial domain $\Omega$ is one-dimensional, and the parameters satisfy $\gamma\theta-\cfrac{m_2 m_1 }{(1+u_*)^2}<0$, we show the existence of Hopf bifurcation. We derive an explicit formula of the bifurcation point $\tau_{n,j}$ where $n, j$ are integers with $n$ has an upper bound. From the Proposition 2.3 of [4], we get that the smallest value of $\tau_{n,j}$ is $\tau_{0,0}$, which indicates that the periodic solutions bifurcated from the constant steady state solutions at $\tau=\tau_{0,0}$ are homogeneous. We have also studied the direction of Hopf bifurcation and stability of bifurcating periodic solution, one can see the details in Section 4.

    The rest of the paper is organized as follows. In Section 2, the existence and priori bound of a positive solution for the reaction diffusion system are given, and the global asymptotically stability of positive equilibrium is proved. In Section 3, the stability of the positive constant steady state is considered, and the existence of the related Hopf bifurcation at the critical points is investigated with delay as the bifurcation parameter. In Section 4, by applying the normal form theory and center manifold reduction of partial functional differential equations, some detailed results of Hopf bifurcation are derived. Some numerical simulations are presented in Section 5. Throughout the paper, we denote $\mathbb{N}$ as the set of positive integers.


    2. Analysis of solution for model without delay


    2.1. Existence and priori bound of solution

    In this section, we shall investigate the existence of a positive solution for system (3) with delay $\tau=0$, and give a priori bound of the solution.

    Clearly, the system (3) with $\tau=0$ is

    $ {u(x,t)td1Δu(x,t)=u(x,t)(1γu(x,t))m1u(x,t)v(x,t),xΩ, t>0,v(x,t)td2Δv(x,t)=θv(x,t)(1v(x,t))+m2u(x,t)v(x,t)1+u(x,t),xΩ, t>0,uν = uν =0,xΩ, t>0,u(x,0)=u0(x)0(0), v(x,0)=v0(x)0(0),xΩ,
    $
    (4)

    where $u_0(x)=u_0(x,0),~v_0(x)=v_0(x,0)$.

    Theorem 2.1. Suppose that $d_1,~d_2,~\theta,~\gamma,~m_1,~m_2$ are all positive, $\Omega\subset\mathbb{R}^n$ is a bounded domain with smooth boundary. Then

    $(a)$ the system (4) has a unique solution $(u(x,t),~v(x,t))$ satisfying

    $ 0<u(x,t)\leq u^*(t),~0<v(x,t)\leq v^*(t),~for~t>0~and~x\in\Omega, $

    where $(u^*(t),~v^*(t))$ is the unique solution of

    $ \left\{ {dudt=u(1γu)dvdt=θv(1v)+m2uv1+u,u(0)=u0,v(0)=v0,
    } \right. $
    (5)

    and

    $ u_0=\sup\limits_{x\in\overline{\Omega}}u_0(x), ~~~~v_0=\sup\limits_{x\in\overline{\Omega}}v_0(x); $

    $(b)$ for any solution $(u(x,t),~v(x,t))$ of system (4),

    $ \limsup\limits_{t\to\infty} u(x,t)\leq \cfrac{1}{\gamma} ,~~~~\limsup\limits_{t\to\infty} v(x,t)\leq 1+\cfrac{m_2}{\theta}. $

    Proof. Define

    $ f(u,v)=u(1-\gamma u)-m_1 uv,~~~~~~g(u,v)=\theta v(1-v)+\cfrac{m_2 uv}{1+u}. $

    Obviously, for any $(u,v)\in{\mathbb{R}}^2_+=\{(u,v)|u\geq 0,~v\geq 0\}$, one can see that

    $ \text{D}f_v=-m_1 u\leq 0 ,~~~~ \text{D}g_u=\cfrac{m_2 v}{(1+u)^2}\geq 0, $

    thus system (4) is a mixed quasi-monotone system(see[23]). Let

    $ (\underline{u}(x,t),~\underline{v}(x,t))=(0,~0)~~ \mbox{and} ~~(\bar{u}(x,t),~\bar{v}(x,t))=(u^*(t),~v^*(t)). $

    Substitute $(\underline{u},~\underline{v})$, $(\bar{u},~\bar{v})$ into system (4) gives

    $ \cfrac{\partial \bar{u}}{\partial t}-d_1\Delta\bar{u}-f(\bar{u},\underline{v})=0\geq 0=\cfrac{\partial\underline{u}}{\partial t}-d_1\Delta \underline{u}-f(\underline{u},\bar{v}), $
    $ \cfrac{\partial \bar{v}}{\partial t}-d_2\Delta\bar{v}-g(\bar{u},\bar{v})=0\geq 0=\cfrac{\partial\underline{v}}{\partial t}-d_2\Delta \underline{v}-g(\underline{u},\underline{v}), $

    and

    $ 0\leq\ u_0(x)\leq u_0,~~~~0\leq v_0(x)\leq v_0. $

    Then $(\underline{u}(x,t),\underline{v}(x,t))=(0,~0)$ and $(\bar{u}(x,t),~\bar{v}(x,t))=(u^*(t),~v^*(t))$ are the lower-solution and upper-solution of system (4), respectively. From Theorem 5.3.3 in [34], we know that system (4) has a unique solution $(u(x,t),v(x,t))$ which satisfies

    $ 0\leq u(x,t)\leq u^*(t),~~0\leq v(x,t)\leq v^*(t),~t\geq0. $

    Since $u_0(x)\not\equiv 0$, $v_0(x)\not\equiv 0$, from the strong maximum principe, we have $u(x,t),v(x, t)>0$ when $t>0$ for all $x\in\Omega$. This completes the proof of part (a).

    Let $u^1(t)$ be the unique solution of

    ${dudt=u(1γu),u(0)=u0>0.
    $

    One can see that $u^1(t)\to 1/\gamma$ as $t\to\infty$, then for any $\varepsilon>0$, there exists a $T_0>0$ such that

    $ u(x,t)\leq 1/\gamma+\varepsilon ,~~~~ \mbox{for}~~t\geq T_0~~\mbox{and}~~x\in\overline{\Omega}, $

    which implies that

    $ \limsup\limits_{t\to\infty}u(x,t)\leq 1/\gamma. $

    Let $v^1(t)$ be the unique solution of

    $ {dvdt=θv(1v)+m2v,v(0)=v0.
    $

    Then we have $v^1(t)\to 1+\cfrac{m_2}{\theta}$ as $t\to\infty$. From

    $ \theta v(1-v)+\cfrac{m_2 uv}{1+u}\leq\theta v(1-v)+m_2 v, $

    it follows that $v(x,t)\leq v^*(t)\leq v^1(t)$. Hence, for any $\varepsilon'>0$, there exists a $T_0'>0$ such that

    $ v(x,t)\leq 1+\cfrac{m_2}{\theta}+\varepsilon'~~ \mbox{for}~~t\geq T_0'~~\mbox{and}~~x\in\overline{\Omega}, $

    which implies that

    $ \limsup\limits_{t\to\infty}v(x,t)\leq 1+\cfrac{m_2}{\theta}. $

    The proof is complete.


    2.2. Global stability of positive equilibrium

    In this section, we shall give the conditions to ensure that the positive constant equilibrium $E_*(u_*,v_*)$ is globally asymptotically stable by utilizing the upper-lower solution method introduced by Pao [24].

    Theorem 2.2. Suppose that $d_1,~d_2,~\theta,~\gamma,~m_1$ and $m_2$ are all positive, and $(H1)$ and

    $ (H2)m_1\left(1+\cfrac{m_2}{\theta(1+\gamma)}\right)<1 $

    are satisfied. Then the positive equilibrium $E_*(u_*,v_*)$ of (4) is globally asymptotically stable, that is $E_*(u_*,v_*)$ is stable, and for any initial values $u_0(x)\geq 0(~\not\equiv 0),~v_0(x)\geq 0(~\not\equiv 0)$,

    $ \lim\limits_{t\to\infty}u(x,t)=u_*,~\lim\limits_{t\to\infty}v(x,t)=v_*,~~ \mbox{for}~~ x\in\overline{\Omega}. $

    Proof. In Section 2.1, we get that

    $u(x,t)\leq 1/\gamma+\varepsilon, ~~~ \mbox{for}~~ t>T_0,~~x\in\overline{\Omega}.$

    From $(H2)$, we can choose an $\varepsilon_0>0$ satisfying

    $ m_1+(1+m_1)\varepsilon_0+\cfrac{m_1 m_2(1+\gamma \varepsilon_0)}{\theta(1+\gamma+\gamma \varepsilon_0)}<1. $ (6)

    Let $\bar{c}_1=1/\gamma+\varepsilon_0$, without loss of generality, there exists a $T_1>0$, such that $u(x,t)\leq 1/\gamma+\varepsilon_0$ for any $t>T_1$, and this in turn implies

    $ \cfrac{\partial v}{\partial t}=d_2 \Delta v+\theta v(1-v)+\cfrac{m_2u v}{1+u}\leq d_2 \Delta v+\theta v(1-v)+\cfrac{m_2 \bar{c}_1 v}{1+\bar{c}_1}, $

    for $t>T_1$. Hence there exists a $T_2>T_1$, such that $v(x,t)\leq \bar{c}_2$ for any $t>T_2$, where

    $ \bar{c}_2=1+\cfrac{m_2 \bar{c}_1 }{\theta(1+\bar{c}_1)}+\varepsilon_0. $

    Again we have

    $ \cfrac{\partial u}{\partial t}=d_1 \Delta u+u(1-\gamma u)-m_1 uv\geq d_1 \Delta u+u(1-\gamma u)-m_1 u\bar{c}_2, $

    for $t>T_2$. Since $m_1<1$ and $\varepsilon_0$ satisfies (6), then

    $ 1-m_1 \bar{c}_2>0, ~~ \mbox{and}~~~ 1-m_1 \bar{c}_2-\varepsilon_0>0. $

    Hence, there exists a $T_3>T_2$, such that $u(x,t)\geq\underline{c}_1>0$ for any $t>T_3$, where

    $ \underline{c}_1=\cfrac{1}{\gamma}(1-m_1 \bar{c}_2-\varepsilon_0). $

    Finally, using the similar method shown above, we have

    $ \cfrac{\partial v}{\partial t}=d_2 \Delta v+\theta v(1-v)+\cfrac{m_2u v}{1+u}\geq d_2 \Delta v+\theta v(1-v)+\cfrac{m_2 \underline{c}_1 v}{1+\underline{c}_1}, $

    for $t>T_3$, and we can ensure the following inequalities hold since $\varepsilon_0$ chosen as in (6),

    $ 1+\cfrac{m_2 \underline{c}_1}{\theta(1+\underline{c}_1)}>1,~~\mbox{and}~~1+\cfrac{m_2 \underline{c}_1}{\theta(1+\underline{c}_1)}-\varepsilon_0>1. $

    Then there exists a $T_4>T_3$ such that $v(x,t)\geq\underline{c}_2>0$ for any $t>T_4$, where

    $ \underline{c}_2=1+\cfrac{m_2 \underline{c}_1}{\theta(1+\underline{c}_1)}-\varepsilon_0. $

    Therefor for $t>T_4$, we obtain that

    $ \underline{c}_1\leq u(x,t)\leq \bar{c}_1,~~~~\underline{c}_2\leq v(x,t)\leq \bar{c}_2, $

    and $\underline{c}_1$, $\bar{c}_1$, $\underline{c}_2$, $\bar{c}_2$ satisfy

    $ 1-\gamma \bar{c}_1-m_1 \underline{c}_2\leq 0,~~ 1-\bar{c}_2+\cfrac{m_2 \bar{c}_1}{\theta(1+\bar{c}_1)}\leq 0, $
    $ 1-\gamma \underline{c}_1-m_1 \bar{c}_2\geq 0,~~ 1-\underline{c}_2+\cfrac{m_2 \underline{c}_1}{\theta(1+\underline{c}_1)}\geq 0. $

    Then $(\bar{c}_1,~\bar{c}_2)$ and $(\underline{c}_1,~\underline{c}_2)$ are a pair of coupled upper and lower solutions of system (4), and when $\underline{c}_1\leq u\leq \bar{c}_1$, $\underline{c}_2\leq v\leq \bar{c}_2$, from the boundedness of the partial derivative of $f_i(i=1,2)$ with respect to $u,~v$, we know that $f_i$ satisfies the Lipschitz condition. Here we denote the Lipschitz constants by $L_i,~i=1,2$.

    To investigate the asymptotic behavior of the positive equilibrium, we define two sequences of constant vectors $({\bar{u}^{(m)},~\bar{v}^{(m)}})$, $({\underline{u}^{(m)},~\underline{v}^{(m)}})$ from the recursion

    $ {ˉu(m)=ˉu(m1)+1L1[ˉu(m1)(1γˉu(m1))m1ˉu(m1)v_(m1)],u_(m)=u_(m1)+1L1[u_(m1)(1γu_(m1))m1u_(m1)ˉv(m1)],ˉv(m)=ˉv(m1)+1L2[θˉv(m1)(1ˉv(m1))+m2ˉu(m1)ˉv(m1)1+ˉu(m1)],v_(m)=v_(m1)+1L2[θv_(m1)(1v_(m1))+m2u_(m1)v_(m1)1+u_(m1)],
    $
    (7)

    where $(\bar{u}^{(0)},~\bar{v}^{(0)})$ = $(\bar{c}_{1},\bar{c}_{2})$, $(\underline{u}^{(0)},~\underline{v}^ {(0)})$ = $(\underline{c}_{1},\underline{c}_{2})$, $L_{i}$ is the Lipschitz constant, $i=1,2$, and $m=1,2,3,\cdots$.

    Then for $m\geq 1$, we know that

    $(u_(0),v_(0))(u_(m),v_(m))(u_(m+1),v_(m+1))(ˉu(m+1), ˉv(m+1))(ˉu(m), ˉv(m))(ˉu(0), ˉv(0)),
    $

    and

    $ (\bar{u}^{(m)},~\bar{v}^{(m)})\rightarrow(\bar{u},\bar{v}), ~(\underline{u}^{(m)},~\underline{v}^{(m)})\rightarrow(\underline{u},\underline{v}),~~\mbox{as}~~m\rightarrow\infty. $

    From the recursion (7), we can obtain that $\bar{u}, \underline{u}, \bar{v}, \underline{v}$ satisfy

    $ ˉu(1γˉu)m1ˉuv_=0,  θˉv(1ˉv)+m2ˉuˉv1+ˉu=0,u_(1γu_)m1u_ˉv=0,  θv_(1v_)+m2u_ v_1+u_=0.
    $
    (8)

    Simplify the equations, we get

    $ \gamma (\bar{u}-\underline{u})=m_1(\bar{v}-\underline{v}),~m_2(\bar{u}-\underline{u})=\theta(1+\bar{u})(1+\underline{u})(\bar{v}-\underline{v}). $

    Then we obtain

    $ \cfrac{\gamma}{m_1}(\bar{u}-\underline{u})=\cfrac{m_2(\bar{u}-\underline{u})}{\theta(1+\bar{u})(1+\underline{u})}. $ (9)

    If we assume that $\bar{u}\neq\underline{u}$, then we can get the following relation from Eq.(9)

    $ \cfrac{\underline{u}}{1+\underline{u}}=1-\cfrac{\theta \gamma(1+\bar{u})}{m_1 m_2}. $ (10)

    From Eq.(8), we can also have

    $ \underline{v}=\frac{1}{m_1}(1-\gamma \bar{u}) ~~ \mbox{and}~~ 1-\underline{v}+\frac{m_2 \underline{u}}{\theta (1+\underline{u})}=0. $ (11)

    Substituting the first equation of Eq.(11) and Eq.(10) into the second equation of Eq.(11), it follows that

    $ 1-\cfrac{1}{m_1}(1-\gamma \bar{u})+\cfrac{m_2}{\theta}\left(1-\cfrac{\theta \gamma(1+\bar{u})}{m_1 m_2}\right)=0, $

    that is

    $ \cfrac{1}{m_1}=\cfrac{m_2}{\theta(1+\gamma)}+\cfrac{1}{1+\gamma}. $ (12)

    This is a contraction to the condition $(H2)$. Hence $\bar{u}=\underline{u}$, and consequently $\bar{v}=\underline{v}$. Then from the Theorem 3.3 in [25] and Corollary 2.1 in [24], we can get the asymptotic behavior of the positive solution.

    Now we investigate the local stability of positive equilibrium $E_*(u_*,v_*)$. Recall that by writing the vector $(u(x,t),v(x,t))^T$ as

    $ U(t):=(u(t),v(t))^T. $

    Then the system (4) can be rewritten as

    $ \dot{U}(t)=D\Delta U(t)+F(U), $ (13)

    where

    $ D=\text{diag}\{d_1,d_2\},~~\mbox{and}~~F:X\to \mathbb{R}^2, $

    is defined by

    $ F(U)=\left(u(t)(1γu(t))m1u(t)v(t)θv(t)(1v(t))m2u(t)v(t)1+u(t)
    \right). $

    We consider the linearization at $E_*(u_*,v_*)$ for

    $ \dot{U}(t)=D\Delta U(t)+L_{E_*}(U), $ (14)

    where

    $ L_{E_*}=\left(γum1um2v(1+u)2θv
    \right),\\ $

    and its characteristic equation satisfies

    $ \lambda\xi-D\Delta \xi-L_{E_*}\xi=0. $ (15)

    It is well known that the eigenvalue problem

    $ -\Delta \varphi = \mu \varphi, \quad x\in (0,l\pi), \quad \quad \varphi_x|_{x=0, l\pi}=0, $

    has eigenvalues

    $ \mu_n=n^2/l^2, n\in\mathbb{N}_0=\mathbb{N}\cup\{0\}, $

    with corresponding eigenfunctions $\varphi_n(x)=\cos(nx/l), n\in\mathbb{N}_0$. Let

    $ \left(ϕψ
    \right)=\sum\limits_{n=0}^\infty\left(anbn
    \right)\cos(nx/l),~~a_n,~b_n\in \mathbb{C}, $

    be an eigenfunction for (15). Then from a straightforward computation, we obtain that the eigenvalues of (15) can be given by the following equations

    $ \text{det}(\lambda I+D\cfrac{n^2}{l^2}-L_{E_1})=0,~~~~~~~~~n\in\mathbb{N}_0, $

    where $I$ is $2\times2$ unit matrix. That is

    $ \lambda^2-T_n\lambda+D_n+B_*=0, ~~n\in\mathbb{N}_0. $ (16)

    For all $n\in\mathbb{N}_0$ we have

    $ Tn=(d1+d2)n2l2(γu+θv)0,Dn+B=(d1n2l2+γu)(d2n2l2+θv)+m1m2uv(1+u)2>0.
    $

    Then all the roots of Eq.(16) have negative real parts. This implies that the positive equilibrium $E_*(u_*,v_*)$ of (4) is locally asymptotically stable when $m_1<1$. Combining with the global attractivity proved before, we know that the constant positive equilibrium $E_*(u_*,v_*)$ is globally asymptotically stable.

    The above result indicates that $E_*(u_*,v_*)$ attracts all feasible solutions under the condition $(H1)$ and $(H2)$. If $(H2)$ doesn't work but $(H1)$ still holds, then $E_*(u_*,v_*)$ is local asymptotically stable. However, if $m_1>1$, then $E_*(u_*,v_*)$ disappears while $E_1(0,1)$ is global asymptotically stable. The critical curve can be drawn on the $(m_1,\gamma)$ plane (see Fig. 1).

    Figure 1. The critical curve on $(m_1,\gamma)$ plane. Ⅰ: $E_*(u_*,v_*)$ is global asymptotically stable; Ⅱ: $E_*(u_*,v_*)$ is local asymptotically stable; Ⅲ: $E_*(u_*,v_*)$ disappears while $E_1(0,1)$ is global asymptotically stable. The parameters are chosen as follows: $\alpha=0.3$, $K_2=0.2$, $\theta=0.5$ with $m_2=\alpha m_1/K_2$.

    Remark 1. According to the relationship between the original equation (1) and the dimensionless equation (2), we can illustrate the effect of "surplus killing". There are two different functional responses in equation (1), in order to be consistent with the assumptions, let the consumption rate $m_2$ be fixed. If the predation rate $m_1$ is sufficiently small(keeping the other parameters constant), then $(H1)$ and $(H2)$ can be satisfied, biologically, the two species can coexist and keep in a certain density. But if $m_1$ is not small enough such that $(H2)$ holds, this coexistence will be shaken, and only near the equilibrium point, they can maintain this balance. As the parameters continue to change, $(H1)$ is not satisfied, the balance will be completely broken: the population of prey will collapse to zero, and then predator population will grow into its carrying capacity. This's reasonable, because the predator population follows a logistic growth, they will never die out in this case, but the prey doesn't seem to be so fortunate: the predator exhibit a "surplus killing" behaviour, they will keep hunting whenever they can. So, the prey must enhance its fertility rate or reduce the chance of encountering a predator to avoid extinction.

    Remark 2. If $m_1>1$, the boundary equilibrium $E_1(0,1)$ is global asymptotically stable for system (4). In fact, from the equation of predator in system Eq.(4), we have

    $ \cfrac{\partial v}{\partial t}=d_2 \Delta v+\theta v(1-v)+\cfrac{m_2u v}{1+u}\geq d_2 \Delta v+\theta v(1-v). $

    It is well known that the positive solution of latter equation uniformly approach to $1$ as $t\rightarrow \infty$ under the same initial and boundary conditions. Since $m_1>1$, and the unique solution $(u(x,t),v(x,t))$ satisfies the conclusions of Theorem 2.1, then we can choose a sufficient small $\varepsilon>0$ and $T_0>0$ such that $1-\gamma u-m_1(1-\varepsilon)<0$ and $v(x,t)\geq 1-\varepsilon$ for any $t>T_0$. Now, consider the equation of prey in system Eq.(4),

    $ \cfrac{\partial u}{\partial t}=d_1 \Delta u+u(1-\gamma v)-m_1 uv \leq d_2 \Delta u+u(1-\gamma u-m_1(1-\varepsilon)), $

    for $t>T_0$. Hence we have $u(x,t)\rightarrow 0$ as $t\rightarrow \infty$, and this result in turn implies $v(x,t)\rightarrow 0$ as $t\rightarrow \infty$.


    3. Stability of the positive equilibrium and Hopf bifurcation

    In this section, we shall study the stability of the positive constant steady state $E_*(u_*,v_*)$ and the existence of Hopf bifurcation for (3) with $\tau\geq 0$ by analyzing the distribution of the eigenvalues. Here, we restrict ourselves to the case of one dimensional spatial domain $\Omega=(0,~l\pi)$, for which the structure of the eigenvalues is clear, and let the phase space $\mathscr{C}:=C([-\tau,0],X)$.

    The linearization of system (13) at $E_*(u_*,v_*)$ is given by

    $ \dot{U}(t)=D\Delta U(t)+L_*(U_t), $ (17)

    where $L_*:\mathscr{C}\to X$ is defined by

    $ L_*(\phi_t)=L_1\phi(0)+L_2\phi(-\tau), $

    and

    $\begin{array}{l}
    L_1=\left( \begin{array}{cc}
             -\gamma u_*&-m_1 u_*\\
             0 &-\theta v_*

           \end{array}
    \right),~~ L_2=\left( 00m2v(1+u)20
    \right), \end{array}$
    $ \phi(t)=(\phi_1(t),~\phi_2(t))^T,~~\phi_t(\cdot)=(\phi_1(t+\cdot),~\phi_2(t+\cdot))^T. $

    The corresponding characteristic equation satisfies

    $ \lambda \xi-D\Delta \xi-L(e^{\lambda\,\cdot}\xi)=0, $ (18)

    where $\xi\in\text{dom}(\Delta)\setminus\{0\}$. Similar analysis to section 2, we can equivalently transform (18) into the following equations.

    $\det\left(\lambda I+D\cfrac{n^2}{l^2}-L_1-L_2 e^{-\lambda\tau}\right)=0,~~n\in\mathbb{N}_0.$

    That is, each characteristic value $\lambda$ is a root of the equation

    $ \lambda^2-T_n\lambda+D_n+B_*e^{-\lambda\tau}=0, ~~n\in\mathbb{N}_0, $ (19)

    where

    $ Tn=(d1+d2)n2l2γuθv,Dn=(d1n2l2+γu)(d2n2l2+θv),B=m1m2uv(1+u)2.
    $

    Clearly, $\lambda=0$ is not the root of Eq.(19), from the result of Ruan and Wei [29], as parameter $\tau$ varies, the sum of the orders of the zeros of Eq.(19) in the open right half plane can change only if a pair of conjugate complex roots appears on or crosses the imaginary axis. Now we would like to seek critical values of $\tau$ such that there exists a pair of simple purely imaginary eigenvalues.

    Let $\pm i\omega(\omega>0)$ be solutions of the $(n+1)$th equation (19). Then we have

    $-\omega^2-T_n i\omega+D_n+B_*e^{-i\omega\tau}=0.$

    Separating the real and imaginary parts, it follows that

    $ {Bcosωτ=ω2Dn,Bsinωτ=Tnω.
    $
    (20)

    Then we have

    $ \omega^4-(2D_n-T_n^2)\omega^2+D_n^2-B^2_*=0. $ (21)

    Denote $z=\omega^2$. Then (21) can be rewritten in the following form

    $ z^2-(2D_n-T_n^2)z+D_n^2-B_*^2=0, $ (22)

    where

    $ 2D_n-T_n^2=-(d_1^2+d_2^2)\cfrac{n^4}{l^4}-2(d_1\gamma u_*+d_2\theta v_*)-(\gamma^2u_*^2+\theta^2 v_*^2)<0. $

    Hence Eq.(22) has a unique positive root

    $ z_n=\cfrac{2D_n-T_n^2+\sqrt{(2D_n-T_n^2)^2-4(D_n^2-B_*^2)}}{2}, $

    only if $D_n $ and $ B_*$ satisfy $D_n^2-B_*^2<0$.

    From the explicit formula of $D_n$ and $B_*$, we know that $D_n+B_*>0$, for all $n\in\mathbb{N}_0$. Since

    $ D_n-B_*=d_1d_2\cfrac{n^4}{l^4}+(d_1\theta v_*+d_2\gamma u_*)\cfrac{n^4}{l^4}+D_0-B_* \to\infty,~\text{as}~n\to\infty, $

    where

    $ D_0-B_*=\gamma\theta u_*v_*-\cfrac{m_2m_1 u_*v_*}{(1+u_*)^2}, $

    and if

    $ D_0-B_*= u_*v_*\left(\gamma\theta-\cfrac{m_2 m_1 }{(1+u_*)^2}\right)<0, $

    we find a constant $n_*\in\mathbb{N}$ such that for $\forall{n}\in\mathbb{N}_0$

    $ D_n-B_*<0,~~\mbox{for}~~0\leq n< n_*. $

    and

    $ D_n-B_*\geq0,~~\mbox{for}~~n\geq n_*. $

    Here we denote the set

    $ \mathcal{S}=\{n\in\mathbb{N}_0|~D_n-B_*<0\}. $

    By Eq.(20), we have $\sin\omega_n\tau>0$, then

    $ \tau_{n,j}=\cfrac{1}{\omega_n}\left(\arccos\cfrac{\omega_n^{2}-D_n}{B_*}+2j\pi\right),~j\in\mathbb{N}_0,~n\in\mathcal{S}. $ (23)

    Following the work of Cooke and Grassman[6], we have

    Lemma 3.1. Suppose that $(H1)$ and $D_0-B_*<0$ are satisfied. Then

    $ \text{sign}~\alpha'(\tau_{n,j})=1,~~for~j\in\mathbb{N}_0,~n\in\mathcal{S}, $

    where

    $ \alpha(\tau)= ~\textrm{Re}\lambda(\tau). $

    Proof. Substituting $\lambda(\tau)$ into Eq.(19) and taking the derivative with respect to $\tau$, we obtain that

    $ (2\lambda-T_n-\tau B_*e^{-\lambda\tau})\cfrac{\text{d}\lambda}{\text{d}\tau}-\lambda B_*e^{-\lambda\tau}=0. $

    Thus

    $ \left(\cfrac{\text{d}\lambda}{\text{d}\tau}\right)^{-1}=\cfrac{2\lambda-T_n-\tau B_*e^{-\lambda\tau}}{\lambda B_*e^{-\lambda\tau}}. $

    By Eq.(20), we have

    $ Re(dλdτ)1|τ=τn,j=2ωncosωnτn,jTnsinωnτn,jBωn=2ω2n2Dn+T2nB2=T4n4T2nDn+4B2B2.
    $

    Since the sign of $\text{Re}\left(\frac{\text{d}\lambda}{\text{d}\tau}\right)$ is same as that of $\text{Re}\left(\frac{\text{d}\lambda}{\text{d}\tau}\right)^{-1}$, the lemma follows immediately.

    From the Proposition 2.3 of [4], we have that

    $ \tau_{n,j}\leq\tau_{n,j+1},~~\mbox{for all}~~~j\in\mathbb{N}_0,n\in\mathcal{S}, $

    and

    $ \tau_{n,j}\leq\tau_{n+1,j},~~\mbox{for all}~~~j\in\mathbb{N}_0,n\in\mathcal{S}. $

    Then $\tau_{0,0}$ is the smallest $\tau_{n,j}$. Denote $\tau_{0,0}$ as $\tau^*$ so that the stability will change when $\tau$ crosses $\tau^*$. Summarizing the above analysis and indicated by Corollary 2.4 of Ruan and Wei [29], we have the following lemma.

    Lemma 3.2. Assume that $(H1)$ is satisfied.

    $(a)$ If either

    $ T_n^4-4T_n^2D_n+4B_*^2<0, $

    or

    $ T_n^4-4T_n^2D_n+4B_*^2\geq0~~and~~\gamma\theta -\cfrac{m_2 m_1}{(1+u_*)^2}>0, $

    for all $n\in\mathbb{N}_0$, then all the roots of (19) have negative real parts for $\tau\geq0$.

    $(b)$ If

    $ \gamma\theta -\cfrac{m_2 m_1}{(1+u_*)^2}<0, $

    then for

    $ \tau=\tau_{n,j}~~,~~j\in\mathbb{N}_0,~n\in\mathcal{S}, $

    the $(n+1)$th equation of (19) has a pair of simple pure imaginary roots $\pm i\omega_n$, and all other roots have non-zero real parts. Moreover, all the roots of Eq.(19) have negative real parts for $\tau\in[0,\tau^*)$, and for $\tau>\tau^*$, Eq.(19) has at least one pair of conjugate complex roots with positive real parts.

    From Lemmas 3.1 and 3.2, we have the following theorem.

    Theorem 3.3. Assume that $(H1)$ is satisfied.

    $(a)$ If

    $ T_n^4-4T_n^2D_n+4B_*^2<0, $

    or

    $ T_n^4-4T_n^2D_n+4B_*^2\geq0~~and~~\gamma\theta -\cfrac{m_2 m_1}{(1+u_*)^2}>0, $

    for all $n\in\mathbb{N}_0$, then the equilibrium point $E_*(u_*,v_*)$ of system (3) is locally asymptotically stable for $\tau\geq0$.

    $(b)$ If

    $ \gamma\theta-\cfrac{m_2 m_1 }{(1+u_*)^2}<0, $

    then system (3) undergoes a Hopf bifurcation at the equilibrium $E_*(u_*,v_*)$ when $\tau=\tau_{n,j}$, for $j\in\mathbb{N}_0,~n\in\mathcal{S}$. Furthermore, the positive equilibrium $E_*(u_*,v_*)$ of system (3) is asymptotically stable for $\tau\in[0,\tau^*)$, and unstable for $\tau>\tau^*$.


    4. Direction of Hopf bifurcation and stability of bifurcating periodic solution

    In section 3, we obtained some conditions under which the system (3) undergoes a Hopf bifurcation. In this section, we shall study the direction of Hopf bifurcation near the positive equilibrium and stability of the bifurcating periodic solutions. We are able to show more detailed information of Hopf bifurcation by using the normal form theory and center manifold reduction due to [10,13,33].

    Rescaling the time $t\mapsto t/\tau$, and let $\tilde{u}(x,t)=u(x,t)-u_*$, $\tilde{v}(x,t)=v(x,t)-v_*$, then we have

    $ {˜ut=τ[d1Δ˜uγu˜um1u˜vf1(ut,vt)],xΩ, t>0,˜vt=τ[d2Δ˜vθv˜v+m2v(1+u)2ut(1)+f2(ut,vt)],xΩ, t>0,˜uν=0, ˜vν=0,xΩ, t>0,˜u(x,t)=˜u0(x,t), ˜v(x,t)=˜v0(x,t),xΩ,1t0,
    $
    (24)

    where

    $ u_t=u(x,t+\theta),~v_t=v(x,t+\theta),~~\theta\in [-1,0], $
    $ \tilde{u}_0(x,t)=u_0(x,t)-u_*,~~\tilde{v}_0(x,t)=v_0(x,t)-v_*, $

    and for $(\phi_1, \phi_2)\in \mathcal{C}:=C([-1,0],X)$

    $ f_1(\phi_1,\phi_2)=-\gamma\phi_1(0)^2-m_1 \phi_1(0)\phi_2(0), $ (25)
    $ f2(ϕ1,ϕ2)=θϕ2(0)2+m2(1+u)2ϕ1(1)ϕ2(0)m2v(1+u)3ϕ1(1)2m2(1+u)3ϕ1(1)2ϕ2(0)+m2v(1+u)4ϕ1(1)3+O(4).
    $
    (26)

    Let $\tau=\tau^*+\epsilon$, from the discussion in section 4, we know that when $\epsilon=0$ system (24) undergoes a Hopf bifurcation at the equilibrium $(0,0)$. Then we can rewrite system (24) in a abstract form in the space $\mathcal{C}$ as

    $ \dot{U}(t)=\tilde{D}\Delta U(t)+L_\epsilon(U_t)+F(\epsilon,U_t), $ (27)

    where

    $ \widetilde{D}=(\tau^*+\epsilon)D~~\mbox{and}~~L_\epsilon:\mathcal{C}\to X,~F:\mathcal{C}\to X $

    are defined, respectively, by

    $ L_\epsilon(\phi(\theta))=(\tau^*+\epsilon)L_1\phi(0)+(\tau^*+\epsilon)L_2\phi(-1), $
    $ F(\epsilon,\phi(\theta))=(F_1(\epsilon,\phi(\theta)),~F_2(\epsilon,\phi(\theta)))^T, $

    with

    $ (F_1(\epsilon,\phi(\theta)),~F_2(\epsilon,\phi(\theta)))=(\tau^*+\epsilon)(f_1(\phi_1(\theta),\phi_2(\theta)),~f_2(\phi_1(\theta),\phi_2(\theta))), $

    where $f_1$ and $f_2$ are defined by (25) and (26) respectively.

    The linearized equation at the origin $(0,0)$ has the form

    $ \dot{U}(t)=\widetilde{D}\Delta U(t)+L_\epsilon(U_t). $ (28)

    According to the theory of semigroup of linear operator [26], we have the solution operator of (28) is a $C_0$-semigroup, and the infinitesimal generator $\mathcal{A}_{\epsilon}$ is given by

    $ \mathcal{A}_{\epsilon}\phi={˙ϕ(θ),θ[1,0),˜DΔϕ(0)+Lϵ(ϕ),θ=0,
    $
    (29)

    with

    $ \text{dom}(\mathcal{A}_\epsilon):=\{\phi\in\mathcal{C}: \dot{\phi}\in\mathcal{C}, \phi(0)\in\text{dom}(\Delta), \dot{\phi}(0)=\widetilde{D}\Delta\phi(0)+L_{\epsilon}(\phi)\}. $

    When $\tau=0$, we denote the infinitesimal generator as $\mathcal{A}_0$.

    Hence, equation (27) can be rewritten as the abstract ODE in $\mathcal{C}$:

    $ \dot{U}_t=\mathcal{A}_\epsilon U_t+X_0 F(\epsilon,U_t), $ (30)

    where

    $ X_0(\theta)={0,θ[1,0),I,θ=0.
    $

    We denote

    $ b_n=\cfrac{\cos (nx/l)}{\|\cos(nx/l)\|},~ ~\beta_n=\{(b_n, 0)^{T}, (0, b_n)^{T}\}, $

    where

    $ \|\cos(nx/l)\|=\left(\int_0^{l\pi}\cos^2(nx/l)\text{d}x\right)^{\frac{1}{2}}. $

    For $\phi=(\phi^{^{(1)}},\phi^{^{(2)}})^{T}\in\mathcal{C}$, denote

    $ \phi_n=\langle \phi,\beta_n\rangle=\left(\langle \phi^{^{(1)}},b_n\rangle, \langle \phi^{^{(2)}},b_n\rangle\right)^{T}. $

    Define $\mathcal{A}_{\epsilon, n}$ as

    $ \mathcal{A}_{\epsilon, n}(\phi_n(\theta)b_n)={˙ϕn(θ)bn,θ[1,0),01dηn(ϵ,θ)ϕn(θ)bn,θ=0,
    $
    (31)

    and

    $ L_{\epsilon, n}(\phi_n)=(\tau^*+\epsilon)L_1\phi_n(0)+(\tau^*+\epsilon)L_2\phi_n(-1), $
    $ \int_{-1}^{0}\text{d}\eta_n(\epsilon,\theta)\phi_n(\theta)=-\cfrac{n^2}{l^2} \widetilde{D}\phi_n(0)+L_{\epsilon,n}(\phi_n), $

    where

    $ \eta_n(\epsilon,\theta)={(τ+ϵ)L2,θ=1,0,θ(1,0),(τ+ϵ)L1n2l2˜D,θ=0.
    $

    Denote $\mathcal{A}^*$ as the adjoint operator of $\mathcal{A}_0$ on $\mathcal{C}^*:=C([0,1],X)$.

    $ \mathcal{A}^*\psi(s)={˙ψ(s), s(0,1],n=001dηTn(0,θ)ψn(θ)bn, s=0.
    $

    Following [10], we introduce the bilinear formal $(\cdot,\cdot)$ on $\mathcal{C}^*\times\mathcal{C}$

    $ (\psi,\phi)=\sum\limits_{k,j=0}^\infty(\psi_k,\phi_j)_c\int_\Omega b_kb_j\text{d}x, $

    where

    $ \psi=\sum\limits_{n=0}^\infty \psi_nb_n\in\mathcal{C}^*,~\phi=\sum\limits_{n=0}^\infty \phi_nb_n\in\mathcal{C}, $

    and

    $ \phi_n\in C:=C([-1,0],\mathbb{R}^2),~~\psi_n\in C^*:=C([0,1],\mathbb{R}^2). $

    Notice that

    $ \int_\Omega b_kb_j\text{d}x=0~~\mbox{for}~~k\neq j, $

    we have

    $ (\psi,\phi)=\sum\limits_{n=0}^\infty(\psi_n,\phi_n)_c|b_n|^2, $

    where $(\cdot,\cdot)_c$ is the bilinear form defined on $C^*\times C$

    $ (\psi_n,\phi_n)_c=\overline{\psi}_n^T(0)\phi_n(0)-\int_{-1}^0\int_{\xi=0}^\theta\overline{\psi}_n^T(\xi-\theta) \text{d}\eta_n(0,\theta)\phi_n(\xi)\text{d}\xi. $

    Let

    $ q(\theta)b_{n_0}=q(0)e^{i\omega_{n_0}\tau^*\theta}b_{n_0}, ~q^*(s)b_{n_0}=q^*(0)e^{i\omega_{n_0}\tau^* s}b_{n_0} $

    be the eigenfunctions of $\mathcal{A}_0$ and $\mathcal{A}^*$ corresponding to the eigenvalues $i\omega_{n_0}\tau^*$ and $-i\omega_{n_0}\tau^*$, respectively. By direct calculations, we chose

    $ q(0)=(1, q_1)^{T},~q^*(0)=M(q_2, 1)^{T}, $

    so that $(q^*,q)_{c}=1$, where

    $q1=iωn0+d1n20/l2+γum1u, q2=iωn0d2n20/l2θvm1u,¯M=(1+u)2(q1+ˉq2)(1+u)2+τm2veiωn0τ.
    $

    Then we decompose the space $\mathcal{C}$ as follows

    $ \mathcal{C}=P\oplus Q, $

    where

    $ P=\{zqb_{n_0}+\overline{z}\overline{q}b_{n_0}|z\in\mathbb{C}\}, $
    $ Q=\{\phi\in\mathcal{C}|(q^*b_{n_0},\phi)=0~\text{and}~(\overline{q}^*b_{n_0},\phi)=0\}. $

    That is $P$ is the 2-dimensional center subspace spanned by the basis vectors of the linear operator $\mathcal{A}_0$ associated with purely imaginary eigenvalues $\pm i\omega_{n_0}\tau_*$, and $Q$ is the complement space of $P$.

    Thus, system (30) could be rewritten as

    $ U_t=z(t)q(\cdot)b_{n_0}+\bar{z}(t)\bar{q}(\cdot)b_{n_0}+W(t,\cdot), $

    where

    $ z(t)=(q^*b_{n_0}, U_t),~~~W(t,\cdot)\in Q, $ (32)

    and

    $ W(t,\theta)=U_t(\theta)-2\text{Re}\{z(t)q(\theta)b_{n_0}\}. $ (33)

    Then we have

    $ \dot{z}(t)=i\omega_0z(t)+\bar{q}^{*T}(0)\langle F(0, U_t), \beta_{n_0}\rangle, $ (34)

    where

    $ \langle F, \beta_{n} \rangle:=(\langle F_1, b_{n}\rangle,\langle F_2, b_{n} \rangle)^T. $

    It follows from Appendix A of [13](also see [18]), there exists a center manifold $\mathscr{C}_0$ and we can write $W$ in the following form on $\mathscr{C}_0$ nearby $(0,0)$:

    $ W(t,\theta)=W(z(t),\bar{z}(t),\theta)=W_{20}(\theta)\frac{z^2}{2}+W_{11}(\theta)z\bar{z} +W_{02}(\theta)\frac{\bar{z}^2}{2}+\cdots, $ (35)

    For solution $U_t\in\mathscr{C}_0$, we denote

    $ F(0, U_t)\mid _{\mathscr{C}_0}=\tilde{F}(0, z, \bar{z}), $

    and

    $ \tilde{F}(0, z, \bar{z})=\tilde{F}_{20}\frac{z^2}{2}+\tilde{F}_{11}z\bar{z}+\tilde{F}_{02}\frac{\bar{z}^2}{2} +\tilde{F}_{21}\frac{z^2\bar{z}}{2}+\cdots. $

    Therefore the system restricted to the center manifold is given by

    $ \dot{z}(t)=i\omega_0z(t)+g(z,\bar{z}), $

    and denote

    $g(z,\bar{z})=g_{20}\frac{z^2}{2}+g_{11}z\bar{z}+g_{02}\frac{\bar{z}^2}{2} +g_{21}\frac{z^2\bar{z}}{2}+\cdots.$

    By direct calculation, we get

    $g20=τˉMlπ0b3n0dx[ˉq2(2γ2m1q1)2θq21+2m2q1(1+u)2eiωn0τ2m2v(1+u)3ei2ωn0τ],g11=τˉMlπ0b3n0dx[ˉq2(2γm1(q1+ˉq1))2θq1ˉq1+m2(1+u)2(q1eiωn0τ+ˉq1eiωn0τ+)2m2v(1+u)3],
    $
    $ g02=τˉMlπ0b3n0dx[ˉq2(2γ2m1ˉq1)2θˉq21+2m2ˉq1(1+u)2eiωn0τ2m2v(1+u)3ei2ωn0τ],g21=τˉM(Q1lπ0b4n0dx+Q2lπ0b2n0dx),
    $

    where

    $ Q1=6m2v(1+u)4eiωn0τ2m2(1+u)3(2q1+ˉq1ei2ωn0τ),Q2=ˉq2{2γ[W(1)20(0)+2W(1)11(0)]m1[W(2)20(0)+2W(2)11(0)+ˉq1W(1)20(0)+2q1W(1)11(0)]}2θ[ˉq1W(2)20(0)+2q1W(2)11(0)]+m2(1+u)2[ˉq1W(1)20(1)+W(2)20(0)eiωn0τ+2q1W(1)11(1)+2W(2)11(0)eiωn0τ]2m2v(1+u)3[W(1)20(1)eiωn0τ+2W(1)11(1)eiωn0τ].
    $

    Since $g_{20}$, $g_{11}$, $g_{02}$ have no concern with $W(z(t),\bar{z}(t),\theta)$, then they can be calculated by Eq.(34). In order to get $g_{21}$, we need to compute $W_{20}$ and $W_{11}$. From (33), we have

    $ ˙W=˙Ut˙zqbn0˙ˉzˉqbn0={A0W2Re{g(z,ˉz)q(θ)}bn0,θ[r,0),A0W2Re{g(z,ˉz)q(θ)}bn0+˜F,θ=0,A0W+H(z,ˉz,θ),
    $
    (36)

    where

    $ H(z,\bar{z},\theta)=H_{20}(\theta)\frac{z^2}{2}+H_{11}(\theta)z\bar{z}+H_{02}(\theta)\frac{\bar{z}^2}{2}+\cdots. $

    Obviously,

    $ H20(θ)={g20q(θ)bn0ˉg02ˉq(θ)bn0,θ[r,0),g20q(0)bn0ˉg02ˉq(0)bn0+˜F20,θ=0,H11(θ)={g11q(θ)bn0ˉg11ˉq(θ)bn0,θ[r,0),g11q(0)bn0ˉg11ˉq(0)bn0+˜F11,θ=0,.
    $

    Comparing the coefficients of (36) with the derived function of (35), we obtain

    $ (A_0 -2i\omega_0 I)W_{20}(\theta)=-H_{20}(\theta), A_0 W_{11}(\theta)=-H_{11}(\theta),~\cdots. $ (37)

    From (29) and (37), for $\theta\in[-1,0)$, we have

    $ W20(θ)=g20iωn0τ(1q1)eiωn0τθbn0ˉg023iωn0τ(1ˉq1)eiωn0τθbn0+E1e2iωn0τθ,W11(θ)=g11iωn0τ(1q1)eiωn0τθbn0ˉg11iωn0τ(1ˉq1)eiωn0τθbn0+E2,
    $
    (38)

    where $E_1$ and $E_2$ can be obtained by setting $\theta=0$ in $H$, that is

    $ (A_0 -2i\omega_{n_0}^+\tau^*I)E_1e^{2i\omega_{n_0}^+\tau^*\theta}\mid_{\theta=0}+\tilde{F}_{20}=0, A_0 E_2\mid_{\theta=0}+\tilde{F}_{11}=0. $ (39)

    The terms $\tilde{F}_{20}$ and $\tilde{F}_{11}$ are elements in the space $\mathscr{C}$, and

    $ \tilde{F}_{20}=\sum\limits_{n=1}^{\infty}\langle \tilde{F}_{20}, \beta_n \rangle b_n, \tilde{F}_{11}=\sum\limits_{n=1}^{\infty}\langle \tilde{F}_{11}, \beta_n \rangle b_n. $

    Denote

    $ E_1=\sum\limits_{n=0}^{\infty}E_1^n b_n,~~E_2=\sum\limits_{n=0}^{\infty}E_2^n b_n, $

    then from (39) we have

    $ (A02iωn0τI)En1bne2iωn0τθθ=0=˜F20,βnbn,A0En2bnθ=0=˜F11,βnbn,n=0,1,.
    $

    Thus, $E_1^n$ and $E_2^n$ could be calculated by

    $ En1=(2iωn0τI01e2iωn0τθdηn(0,θ))1˜F20,βn,En2=(01dηn(0,θ))1˜F11,βn,n=0,1,,
    $

    where

    $\langle \tilde{F}_{20}, \beta_n \rangle={1lπˆF20,n00, n=0,12lπˆF20,n00, n=2n0,1lπˆF20,n0=0, n=0,0,other,
    $
    $\langle \tilde{F}_{11}, \beta_n \rangle={1lπˆF11,n00, n=0,12lπˆF11,n00, n=2n0,1lπˆF11,n0=0, n=0,0,other,
    $
    $\hat{F}_{20}=\left[2γ2m1q12θq21+2m2q1(1+u)2eiωn0τ2m2v(1+u)3ei2ωn0τ
    \right],$
    $\hat{F}_{11}=\left[2γm1(q1+ˉq1)2θq1ˉq1+m2(1+u)2(q1eiωn0τ+ˉq1eiωn0τ)m2v(1+u)3
    \right].$

    Hence, $g_{21}$ could be represented explicitly.

    Denote

    $ c1(0)=i2ωn0τ(g20g112|g11|213|g02|2)+12g21,μ2=Re(c1(0))τRe(λ(τ)),   β2=2Re(c1(0)),T2=1ωn0τ(Im(c1(0))+μ2(ωn0+τIm(λ(τ))).
    $
    (40)

    Then by the general result of Hopf bifurcation theory (see [13]), we know that the parameters in (40) determine the properties of Hopf bifurcation which we can describe specifically: $\beta_2$ determines the stability of the bifurcating periodic solutions: the bifurcating periodic solutions are orbitally asymptotically stable(unstable) if $\beta_2<0(>0)$; $\mu_2$ determines the directions of the Hopf bifurcation: if $\mu_2>0(<0)$, then the direction of the Hopf bifurcation is forward (backward), that is the bifurcating periodic solutions exist when $\tau>\tau^*(<\tau^*)$; and $T_2$ determines the period of the bifurcating periodic solutions: when $T_2>0(<0)$, the period increases(decreases) as the $\tau$ varies away from $\tau^*$.

    From 3.1 in Section 4, we know that $\text{Re}(\lambda'(\tau^*))>0$. Combining with above discuss, we obtain the following theorem

    Theorem 4.1. If $\text{Re}(c_1(0))<0(>0)$, then the bifurcating periodic solutions exists for $\tau>\tau^*(<\tau^*)$ and are orbitally asymptotically stable(unstable).


    5. Simulations

    In this section, we make some simulations to support and extend our analytical results. Taking $l=2$, and choose

    $ \gamma=0.01 ,~~~\theta=0.05 ,~~~m_1=0.20 ,~~~m_2=0.30 ,~~~d_1=1 ,~~~d_2=0.50. $

    Since $m_1=0.2<1$, the positive equilibrium exists, through numerical calculation, we get $E_*(1.8663,4.9067)$. From a simple verification, we also obtain that $D_n-B_*<0$ only for $n=0$. That is $\mathcal{S}=\{0\}$, and

    $ \omega\approx 0.2074,~~~~ \tau^*\approx 4.6242. $

    Furthermore, we have $c_1(0)\approx-0.08872+0.0200i$, that is $\beta<0$. From Theorem 3.3 and 4.1, the positive equilibrium $E_*(1.8663,4.9067)$ is locally asymptotically stable when $\tau\in[0, \tau^*)$ (see Fig. 2), moreover, system (3) undergoes a Hopf bifurcation at $\tau=\tau^*$, the direction of the Hopf bifurcation is forward and bifurcating periodic solutions are orbitally asymptotically stable for $\tau>\tau^*$(see Fig. 3).

    Figure 2. The positive equilibrium is asymptotically stable when $\tau\in[0, \tau^*)$, where $\tau=2<\tau^*\approx4.6242$.
    Figure 3. The bifurcating periodic solution is stable, where $\tau=5>\tau^*\approx4.6242$.

    If we choose

    $ \gamma=0.01 ,~~~\theta=0.05 ,~~~m_1=2 ,~~~m_1=0.30 ,~~~d_1=1 ,~~~d_2=0.50, ~~~\tau=1. $

    Here we chose $m_1=2>1$, then we know that the boundary equilibrium $E_1(0,1)$ is global asymptotically stable (see Fig. 4).

    Figure 4. The axial equilibrium $E_1(0,1)$ is global asymptotically stable.

    The initial conditions in all simulations are given by $u_0(x,t)=1.7+0.1\cos2x, ~v_0(x,t)=4.9-0.1\cos2x$, $(x,t)\in[0,2\pi]\times[-\tau,0]$.

    Remark 3. Fig. 2 and Fig. 3 come into being on the precondition of $(H1)$, that is to say, when the delay $\tau$ is less than the critical value $\tau^*$, the population of predator and prey will tend to a relatively stable state (see Fig. 2); when the delay $\tau$ is a little larger than the critical value $\tau^*$, the polulation presents a periodic oscillation phenomenon near the equilibrium point(see Fig. 3). If the precondition of $(H1)$ is not satisfied, from Remark 1 and Remark 2, we know that the boundary equilibrium $E_1(0,1)$ is global asymptotically stable, the prey will go extinct at last, but the predator will increase and reach its carrying capacity(see Fig. 4).


    Acknowledgments

    The authors greatly appreciate the anonymous referees' careful reading and valuable comments. Their critical comments and helpful suggestions greatly improve the presentation of the manuscript.


    [1] Deming TJ (2014) Preparation and development of block copolypeptide vesicles and hydrogels for biological and medical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6: 283–297.
    [2] Crucho CIC (2015) Stimuli-Responsive Polymeric Nanoparticles for Nanomedicine. Chem Med Chem 10: 24–38. doi: 10.1002/cmdc.201402290
    [3] Hamidi M, Shahbazi MA, Rostamizadeh K (2012) Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy. Macromol Biosci 12: 144–164. doi: 10.1002/mabi.201100193
    [4] Kamaly N, Xiao Z, Valencia PM, et al (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41: 2971–3010. doi: 10.1039/c2cs15344k
    [5] Fleige E, Quadir MA, Haag R (2012) Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 64: 866–884. doi: 10.1016/j.addr.2012.01.020
    [6] Motornov M, Roiter, Y, Tokarev I, et al. (2010) Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems. Prog Polym Sci 35: 174–211. doi: 10.1016/j.progpolymsci.2009.10.004
    [7] Gong J, Chen M, Zheng Y, et al (2012) Polymeric micelles drug delivery system in oncology. J Control Release 159: 312–323.
    [8] Kowalczuk A, Trzcinska R, Trzebicka B, et al. (2014) Loading of polymer nanocarriers: factors, mechanisms and applications. Prog Polym Sci 39: 43–86. doi: 10.1016/j.progpolymsci.2013.10.004
    [9] Zhang Y, Wang C, Huang Y, et al. (2015) Core-crosslinked polymeric micelles with high doxorubicin loading capacity and intracellular pH- and redox-triggered payload release. Eur Polym J 68: 104–114.
    [10] Aluri S, Janib SM, Mackay JA (2009) Environmentallyresponsivepeptides as anticancer drug carriers. Adv Drug Deliver Rev 61: 940–952. doi: 10.1016/j.addr.2009.07.002
    [11] Doty P, Yang JT (1956) Polypeptides VII. Poly-gamma-benzyl-L-glutamate—the helix-coil transition in solution. J Am Chem Soc 78:498–500.
    [12] Blout ER, Lenormant H (1957) Reversible configurational changes in poly-L-lysine hydrochloride induced by water. Nature 179: 960–963. doi: 10.1038/179960a0
    [13] Applequist J (1963) On helix-coil equilibrium in polypeptides. J Chem Phys 38: 934–941. doi: 10.1063/1.1733787
    [14] Soliman M, Allen S, Davies MC, et al. (2010) Responsive polyelectrolyte complexes for triggered release of nucleic acid therapeutics. Chem Commun 46: 5421–5433. doi: 10.1039/c0cc00794c
    [15] Rosu C, Selcuk S, Soto-Cantu E, et al. (2014) Progress in silica polypeptide composite colloidal hybrids: from silica cores to fuzzy shells. Colloid Polym Sci 292: 1009-1040. doi: 10.1007/s00396-014-3170-7
    [16] Holowka EP, Sun VZ, Kamei DT, et al. (2007) Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery. Nat Mater 6 :52–57.
    [17] Battaglia G, Ryan AJ (2005) Bilayers and Interdigitation in Block Copolymer Vesicles. J Am Chem Soc 127: 8757–8764.
    [18] Won YY, Davis HT, Bates FS (1999) Giant Wormlike Rubber Micelles. Science 283: 960–963.
    [19] Geng Y, Dalhaimer P, Cai S, et al. (2007) Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery. Nat Nanotechnol 2: 249–255. doi: 10.1038/nnano.2007.70
    [20] Robertson JD, Yealland G, Avila-Olias, et al. (2014) pH-sensitive tubular polymersomes: Formation and applications in cellular delivery. ACS Nano 8: 4650–4661. doi: 10.1021/nn5004088
    [21] Quadir MA, Martin M, Hammond PT (2014) Clickable Synthetic Polypeptides—Routes to New Highly Adaptive Biomaterials. Chem Mater 26: 461–476. doi: 10.1021/cm4023997
    [22] Such GK, Yan Y, Johnston APR, et al. (2015) Interfacing Materials Science and Biology for Drug Carrier Design. Adv Mater 27: 2278–2297. doi: 10.1002/adma.201405084
    [23] Van Sluis R,Bhujwalla ZM,Raghunand N, et al. (1999) In Vivo Imaging of Extracellular pH Using 1H MRSI. Magnet Reson Med 41:743–750.
    [24] Brahimi-Horn MC,Pouyssegur J (2007)Hypoxia in cancer cell metabolism and pH regulation. Essays Biochem 43: 165–178.
    [25] Qiu Y, Park K (2001) Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 53: 321–39. doi: 10.1016/S0169-409X(01)00203-4
    [26] Majedi FS, Hasani-Sadrabadi MM, VanDersarl JJ, et al. (2013) On-Chip Fabrication of Paclitaxel-Loaded Chitosan Nanoparticles for Cancer Therapeutics. Adv Funct Mater 24: 432–41.
    [27] Bajaj I, Singhal R (2011) Poly (glutamic acid)—an emerging biopolymer of commercial interest. Bioresource Technol 102: 5551–5561. doi: 10.1016/j.biortech.2011.02.047
    [28] Kim W, Yamasaki Y, Jang WD, at al. (2010) Thermodynamics of DNA condensation induced by poly (ethylene glycol)-block-polylysine through polyion complex micelle formation. Biomacromolecules 11: 1180–1186. doi: 10.1021/bm901305p
    [29] Bellomo E, Wyrsta MD, Pakstis L, et al. (2004) Stimuli-responsive polypeptide vesicles by conformation-specific assembly. Nat Mater 3: 244−248.
    [30] Nowak AP, Breedveld V, Pakstis L, et al. (2002) Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature 417: 424−428.
    [31] Holowka EP, Pochan DJ, Deming TJ (2005) Charged Polypeptide Vesicles with Controllable Diameter. J Am Chem Soc 127: 12423–12428. doi: 10.1021/ja053557t
    [32] Carlsen A, Lecommandoux S (2009) Self-assembly of polypeptide-based block copolymer amphiphiles. Curr Opin Colloid In 14: 329–339. doi: 10.1016/j.cocis.2009.04.007
    [33] Quadir MA, Morton SW, Deng ZJ, et al. (2014) PEG–Polypeptide Block Copolymers as pH-Responsive Endosome-Solubilizing Drug Nanocarriers. Mol Pharmaceutics11: 2420–2430.
    [34] Yin H, Kang SW, Bae YH (2009) Polymersome Formation from AB2 Type 3-Miktoarm Star Copolymers. Macromolecules 42: 7456–7464. doi: 10.1021/ma901701w
    [35] Yin H, Kang HC, Huh KM, et al. (2012) Biocompatible, pH-sensitive AB2 miktoarm polymer-based polymersomes: preparation, characterization, and acidic pH-activated nanostructural transformation. J Mater Chem 22: 19168–19178.
    [36] Kragh-Hansen H, Chuang VT, Otagiri M (2002) Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Bio Pharm Bull 25: 695–704 doi: 10.1248/bpb.25.695
    [37] Ming X, Carver K, Wu L (2013) Albumin-Based Nanoconjugates for Targeted Delivery of Therapeutic Oligonucleotides. Biomaterials 34: 7939–7949. doi: 10.1016/j.biomaterials.2013.06.066
    [38] Du C, Deng D, Shan L, at al. (2013) A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Biomaterials 34: 3087–3097. doi: 10.1016/j.biomaterials.2013.01.041
    [39] Xia W, Low PS (2010) Folate-targeted therapies for cancer. J Med Chem 53: 6811–6824. doi: 10.1021/jm100509v
    [40] Sudimack J, Lee RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41: 147–162. doi: 10.1016/S0169-409X(99)00062-9
    [41] Lu Y, Low PS (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 54: 675–693. doi: 10.1016/S0169-409X(02)00042-X
    [42] Nistor MT, Chiriac AP, Nita LE, et al. (2013) Semi-interpenetrated polymer networks of hyaluronic acid modified with poly(aspartic acid). J Polym Res 20: 86. doi: 10.1007/s10965-013-0086-8
    [43] Mackay JA, Chilkoti A (2008) Temperature sensitive peptides: engineering hyperthermia-directed therapeutics. Int J Hypertherm 24: 483–495. doi: 10.1080/02656730802149570
    [44] Aluri S, Janib SM, Mackay JA (2009) Environmentally responsive peptides as anticancer drug carriers. Adv Drug Deliver Rev 61: 940–952. doi: 10.1016/j.addr.2009.07.002
    [45] Ruszczak Z (2003) Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55: 1595–1611. doi: 10.1016/j.addr.2003.08.003
    [46] Lupas A (1996) Coiled coils: new structures and new functions. Trends Biochem Sci 21: 375–382. doi: 10.1016/S0968-0004(96)10052-9
    [47] Petka WA, Harden JL, McGrath KP, et al. (1998) Reversible hydrogels from self-assembling artificial proteins. Science 281: 389–392.
    [48] Al-Ahmady ZS, Al-Jamal WT, Bossche JV, et al. (2012) Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in Vivo. ACS Nano 6: 9335–9346. doi: 10.1021/nn302148p
    [49] Banta S, Wheeldon IR, Blenner M (2010) Protein engineering in the development of functional hydrogels. Annu Rev Biomed Eng 12:167–186. doi: 10.1146/annurev-bioeng-070909-105334
    [50] Huang HC, Koria P, Parker S, et al. (2008) Optically responsive gold nanorod-polypeptide assemblies. Langmuir 24: 14139–14144. doi: 10.1021/la802842k
    [51] Lin Y, Xia X, Wang M, et al. (2014) Genetically programmable thermoresponsive plasmonic gold/silk-elastin protein core/shell nanoparticles. Langmuir 30: 4406–4414.
    [52] Chilkoti A, Dreher MR, Meyer DE, et al. (2002) Targeted drug delivery by thermally responsive polymers. Adv Drug Deliver Rev 54: 613–630. doi: 10.1016/S0169-409X(02)00041-8
    [53] Maeda H, Seymour LW, Miyamoto Y (1992) Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem 3: 351–362. doi: 10.1021/bc00017a001
    [54] Schmaljohann D (2006) Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliver Rev 58: 1655–1670.
    [55] Raucher D, Massodi I, Bidwell GL (2008) Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin like polypeptide. Expert Opin Drug Deliver 5: 353–369. doi: 10.1517/17425247.5.3.353
    [56] Massodi I, Thomas E, Raucher D (2009) Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules 14: 1999–2015. doi: 10.3390/molecules14061999
    [57] MacEwan SR, Chilkoti A (2010) Elastin-like polypeptides: biomedical applications of tunable biopolymers. Biopolymers 94: 60–77. doi: 10.1002/bip.21327
    [58] Liu W, Dreher MR, Furgeson DY, et al (2006) Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Release 116: 170–178. doi: 10.1016/j.jconrel.2006.06.026
    [59] McDaniel JR, Callahan DJ, Chilkoti A, et al. (2010) Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliver Rev 62: 1456–1467. doi: 10.1016/j.addr.2010.05.004
    [60] Moktan S, Ryppa C, Kratz F, et al. (2012) A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis. Invest New Drugs 30: 236–248. doi: 10.1007/s10637-010-9560-x
    [61] Rousselle C, Smirnova M, Clair P, et al. (2001) Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J Pharmacol Exp Ther 296: 124–13.
    [62] Jiang C, Tsukruk VV, et al. (2006) Freestanding Nanostructures via Layer-by-Layer Assembly. Adv Mater 18: 829–840.
    [63] Johnston APR, Cortez C, Angelatos AS, et al. (2006) Layer-by-layer engineered capsules and their applications. Curr Opin Colloid Interface Sci 11: 203–209.
    [64] Wattendorf U, Kreft O, Textor M, et al. (2008) Stable stealth function for hollow polyelectrolyte microcapsules through a poly(ethylene glycol) grafted polyelectrolyte adlayer. Biomacromolecules 9: 100–108.
    [65] Kamphuis MM, Johnston AP, Such GK, et al. (2010) Targeting of cancer cells using click-functionalized polymer capsules. J Am Chem Soc 132: 15881–15883.
    [66] Golonka M, Bulwan M, Nowakowska M, et al. (2011) Thermoresponsive multilayer films based on ionic elastin-like recombinamers. Soft Matter 7: 9402–9409. doi: 10.1039/c1sm06276j
    [67] Chen X, Zhang W, Li K, et al. (2012) Thermoresponsive oligoprolines. Soft Matter 8: 4869–4872. doi: 10.1039/c2sm25451d
    [68] Chen C, Wang Z, Li Z (2011) Thermoresponsive Polypeptides from Pegylated Poly-l-glutamate. Biomacromolecules 12: 2859–2863. doi: 10.1021/bm200849m
    [69] Fu X, Shen Y, Fu W (2013) Thermoresponsive Oligo(ethylene glycol) Functionalized Poly-l-cysteine. Macromolecules46: 3753–3760.
    [70] Zhang X, Li W, Zhao X, et al. (2013) Thermoresponsive Dendronized Polyprolines via the “Grafting to” Route. Macromol Rapid Commun 34: 1701–1707. doi: 10.1002/marc.201300605
    [71] Yan J, Liu K, Zhang X, at al. (2015) Dynamic covalent polypeptides showing tunable secondary structures and thermoresponsiveness. J Polym Sci A 53: 33–41. doi: 10.1002/pola.27433
    [72] Lam RTS, Belenguer A, Roberts SL (2005) Amplification of Acetylcholine-Binding Catenanes from Dynamic Combinatorial Libraries. Science 308: 667–669. doi: 10.1126/science.1109999
    [73] Carnall JMA, Waudby CA, Belenguer AM, et al (2010) Mechanosensitive Self-Replication Driven by Self-Organization. Science 327: 1502–1506. doi: 10.1126/science.1182767
    [74] Li J, Nowak P, Otto S (2013) Dynamic Combinatorial Libraries: From Exploring Molecular Recognition to Systems Chemistry. J Am Chem Soc 135: 9222–9239. doi: 10.1021/ja402586c
    [75] Matanović MR, Kristl J, Grabnar PA (2014) Thermoresponsive polymers: Insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications. Int J Pharm 472: 262–275.
    [76] Joly-Duhamel C, Hellio D, Djabourov M (2002) All gelatin networks: 1. Biodiversity and physical chemistry. Langmuir 18: 7208–7217.
    [77] Yang H, Kao W (2006) Thermoresponsive gelatin/monomethoxy poly(ethylene glycol)–poly(d,l-lactide) hydrogels: formulation, characterization, and antibacterial drug delivery. Pharm Res 23: 205–214.
    [78] Ohya S, Matsuda T (2005) Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: molecular and formulation parameters vs. cell proliferation potential. J Biomat Sci-Polym 16: 809–827.
    [79] Huang J, Hastings CL, Duffy GP, et al. (2013) Supramolecular Hydrogels with Reverse Thermal Gelation Properties from (Oligo)tyrosine Containing Block Copolymers. Biomacromolecules 14: 200–206. doi: 10.1021/bm301629f
    [80] Cheng Y, He C, Xiao C, et al. (2012) Decisive Role of Hydrophobic Side Groups of Polypeptides in Thermosensitive Gelation. Biomacromolecules 13: 2053–2059. doi: 10.1021/bm3004308
    [81] Park MH, Joo MK, Choi BG, et al. (2012) Biodegradable Thermogels. Acc Chem Res 45: 424–433.
    [82] Oh HJ, Joo MK, Sohn YS, et al. (2008) Secondary Structure Effect of Polypeptide on Reverse Thermal Gelation and Degradation of l/dl-Poly(alanine)–Poloxamer–l/dl-Poly(alanine) Copolymers. Macromolecules 41:8204–8209.
    [83] Zhang S, Fu W, Li Z (2014) Supramolecular hydrogels assembled from nonionic poly(ethylene glycol)-b-polypeptide diblocks containing OEGylated poly-L-glutamate. Polym Chem 5: 3346–3351.
    [84] Zhang DJ, Alvarez MV, Sofroniew TJ (2015) Deming. Design and Synthesis of Nonionic Copolypeptide Hydrogels with Reversible Thermoresponsive and Tunable Physical Properties. Biomacromolecules16: 1331–1340.
    [85] Huang J, Bonduelle C, Thévenot J, et al. (2012) Biologically Active polymersomes from Amphiphilic Glycopeptides. J Am Chem Soc 134: 119–122. doi: 10.1021/ja209676p
    [86] Schatz C, Louguet S, Meins JFL, et al. (2009) Polysaccharide block polypeptide copolymers vesicles towards synthetic viral capsids. Angew Chem Int Ed 48: 2572–2575. doi: 10.1002/anie.200805895
    [87] Zhang A, Zhang Z, Shi F, et al. (2013) Redox-Sensitive Shell-Crosslinked Polypeptide-block-Polysaccharide Micelles for Efficient Intracellular Anticancer Drug Delivery. Macromol Biosci 13: 1249–1258. doi: 10.1002/mabi.201300175
    [88] Liu L, Liu P (2015) Synthesis strategies for disulfide bond-containing polymer-based drug delivery system for reduction-responsive controlled release. Front Mater Sc 9: 211–226. doi: 10.1007/s11706-015-0283-y
    [89] Wang K, Luo GF, Liu Y, et al. (2012) Redox-sensitive shell cross-linked PEG-polypeptidehybrid micelles for controlled drug release. Polym Chem 3: 1084–1090. doi: 10.1039/c2py00600f
    [90] Beloor J, Ramakrishna S, Nam K, et al. (2015) Effective Gene Delivery into Human Stem Cells with a Cell-Targeting Peptide-Modified Bioreducible Polymer. Small 11: 2069–2079. doi: 10.1002/smll.201402933
    [91] Burnett JC, Rossi JJ (2012) RNA-Based Therapeutics: Current Progress and Future Prospects. Chem Biol 19: 60–71. doi: 10.1016/j.chembiol.2011.12.008
    [92] Cavalieri F, Beretta G, Cui J, et al. (2015) Redox-Sensitive PEG–Polypeptide Nanoporous Particles for Survivin Silencing in Prostate Cancer Cells. Biomacromolecules 16: 2168–2178. doi: 10.1021/acs.biomac.5b00562
    [93] Wang Y, Yu A, Caruso F (2005) Nanoporous Polyelectrolyte Spheres Prepared by Sequentially Coating Sacrificial Mesoporous Silica Spheres. Angew Chem Int Ed 44: 2888–2892. doi: 10.1002/anie.200462135
    [94] Manickam DS, Oupický D (2006) Multiblock Reducible Copolypeptides Containing Histidine-Rich and Nuclear Localization Sequences for Gene Delivery. Bioconjugate Chem17: 1395–1403.
    [95] Rosengart AJ, Kaminski MD, Chen HT, et al. (2005) Magnetizable implants and functionalized magnetic carriers: a novel approach for noninvasive yet targeted drug delivery. J Magn Magn Mater 293: 633–638
    [96] Mornet S, Vasseur S, Grasset F, et al. (2006) Magnetic nanoparticle design for medical applications. Prog Solid State Ch 34: 237–47. doi: 10.1016/j.progsolidstchem.2005.11.010
    [97] Lee H, Shao HP, Huang YQ, et al. (2005) Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan. IEEE T Magn 41:4102–4.
    [98] Liu XQ, Kaminski MD, Riffle JS, et al. (2007) Preparation and characterization of biodegradable magnetic carriers by single emulsion-solvent evaporation. J Magn Magn Mater 311: 84–7. doi: 10.1016/j.jmmm.2006.10.1170
    [99] Ju XJ, Xie R, Yang L (2009) Biodegradable ‘intelligent’ materials in response to physical stimuli for biomedical applications. Expert Opin Ther Pat 19: 493–507. doi: 10.1517/13543770902771282
    [100] Aili D, Stevens MM (2010) Bioresponsive peptide-inorganic hybrid nanomaterials. Chem Soc Rev 39: 3358–3370. doi: 10.1039/b919461b
    [101] Pan BF, Cui DX, Sheng Y, et al. (2007) Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 67: 8156–8163. doi: 10.1158/0008-5472.CAN-06-4762
    [102] Digigow RG, Dechézelles JF, Dietsch H, et al. (2014) Preparation and characterization of functional silica hybrid magnetic nanoparticles. J Magn Magn Mater 362: 72–79.
    [103] Digigow RG, Vanhecke D, Rothen-Rutishauser B, et al. (2015)Uptake and Intracellular Fate of Peptide Surface-Functionalized Silica Hybrid Magnetic Nanoparticles In Vitro. Part Part Syst Char 33: 188–196.
    [104] Lerche MH, Jensen PR, Karlsson M, et al. (2015) NMR Insights into the Inner Workings of Living Cells. Anal Chem 87: 119–132.
    [105] Boutin C, Desvaux H, Carrière M, et al. (2011) Hyperpolarized129Xe NMR signature of living biological cells. NMR Biomed 24: 1264–1269. doi: 10.1002/nbm.1686
    [106] Kotera N, Dubost E, Milanole G, et al. (2015) A doubly responsive probe for the detection of Cys4-tagged proteins. Chem Commun 51: 11482–11484. doi: 10.1039/C5CC04721H
    [107] Kwon S, Kim BJ, Lim HK, et al. (2015) Magnetotactic molecular architectures from self-assembly of β-peptide foldamers. Nat Commun 6: 8747. doi: 10.1038/ncomms9747
    [108] Goodman CM, Choi S, Shandler S, et al. (2007) Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol 3: 252–262. doi: 10.1038/nchembio876
    [109] Kwon S, Jeon A, Yoo S, et al. (2010) Unprecedented Molecular Architectures by the Controlled Self-Assembly of a β-Peptide Foldamer. Angew Chem Int Ed 49: 8232–8236. doi: 10.1002/anie.201003302
    [110] Lefèvre CT, Abreu F, Lins U, et al. (2011) A bacterial backbone: magnetosomes in magnetotactic bacteria. M. Rai, N. Duran (Eds.) in Metal nanoparticles in microbiology, Springer-Verlag, Berlin (2011), 75–102.
    [111] Unger E, Metzger P, Krupinski E, et al. (2000) The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol 35: 86–89. doi: 10.1097/00004424-200001000-00010
    [112] Weller GER, Wong MKK, Modzelewski RA, et al. (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65: 533–539.
    [113] Linker RA, Reinhardt M, Bendszus M, et al. (2005) In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmun 25:199–205.
    [114] Sirsi S, Borden M (2009) Microbubble compositions, properties and biomedical applications. Bubble Sci Eng Technol 1: 3–17. doi: 10.1179/175889709X446507
    [115] Cochran MC, Eisenbrey J, Ouma RO, et al. (2011) Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 414:161–170. doi: 10.1016/j.ijpharm.2011.05.030
    [116] Borden MA, Sarantos MR, Stieger SM (2006) Ultrasound radiation force modulates ligand availability on targeted contrast agents. Mol Imag 5:139–147.
    [117] Lum AFH, Borden MA, Dayton PA (2006) Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 111: 128–134. doi: 10.1016/j.jconrel.2005.11.006
    [118] Borden MA,Zhang H, Gillies RJ, et al. (2008) A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 29: 597–606. doi: 10.1016/j.biomaterials.2007.10.011
    [119] Bloch M, Jablonowski L, Yavin E, et al. (2015) Multi-modal detection of colon malignancy by NIR-tagged recognition polymers and ultrasound contrast agents. Int J Pharm 478: 504–516. doi: 10.1016/j.ijpharm.2014.11.066
    [120] Eisenbrey JR, Burstein OM, Kambhampati R, et al. (2010) Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. J Control Release 143: 38–44. doi: 10.1016/j.jconrel.2009.12.021
    [121] Eisenbrey JR, Soulen MC, Wheatley MA (2010) Delivery of encapsulated doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents. IEEE Trans Biomed Eng 57: 24–28. doi: 10.1109/TBME.2009.2030497
    [122] Duncan R, Gac-Breton S, Keane R (2001) Polymer-drug conjugates, PDEPT and PELT: basic principles for design and tranfer from the laboratory to clinic. J Control Release 74: 135–46. doi: 10.1016/S0168-3659(01)00328-5
    [123] Terada T, Iwai M, Kawakami S (2006) Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J Control Release 111: 333–42.
    [124] Lee SJ, Jeong YI, Park HK, et al. (2015) Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancerdrug delivery. Int J Nano 10: 5489–550.
    [125] Secret E, Kelly SJ, Crannell KE, et al. (2014) Enzyme-Responsive Hydrogel Microparticles for Pulmonary Drug Delivery. ACS Appl Mater Interfaces 6: 10313–10321. doi: 10.1021/am501754s
    [126] Secret E, Crannell KE, Kelly SJ, et al. (2015) Matrix metalloproteinase-sensitive hydrogel microparticles for pulmonary drug delivery of small molecule drugs or proteins. J Mater Chem B 3: 5629–5634. doi: 10.1039/C5TB00443H
    [127] Angelos S, Khashab NM, Yang YW, et al. (2009) pH clock-operated mechanized nanoparticles. J Am Chem Soc 131: 12912–12914.
    [128] Luo Z, Ding X, Hu Y, et al. (2013) Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo. ACS Nano 7: 10271–10284. doi: 10.1021/nn404676w
    [129] Li J, Liu F, Shao Q, et al. (2014) Enzyme-Responsive Cell-Penetrating Peptides Conjugated Mesoporous Silica Quantum Dots Nanocarriers for Controlled Release of Nucleus-Targeted Drug Molecules and Real-Time Intracellular Fluorescence Imaging of Tumor Cells. Adv Healthcare Mater 3: 1230–123. doi: 10.1002/adhm.201300613
    [130] Cheng YJ, Luo GF, Zhu JY, et al. (2015) Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles. ACS Appl Mater Interfaces7: 9078–9087.
    [131] Liu J, Zhang B, Luo Z, et al. (2015) Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Nanoscale 7: 3614–3626. doi: 10.1039/C5NR00072F
    [132] del Mercato LL, Ferraro MM, Baldassarre F, et al. (2014) Biological applications of LbL multilayer capsules: From drug delivery to sensing. Adv Colloid Interface Sci 207: 139–154. doi: 10.1016/j.cis.2014.02.014
    [133] De Geest BG, Vandenbroucke RE, Guenther AM, et al. (2006) Intracellularly degradable polyelectrolyte microcapsules. Adv Mater 18: 1005–1009. doi: 10.1002/adma.200502128
    [134] Ochs CJ, Such GK, Yan Y, et al. (2010) Biodegradable click capsules with engineered drug-loaded multilayers. Acs Nano 4: 1653–1663. doi: 10.1021/nn9014278
    [135] Aller SG, Yu J, Ward A, et al. (2009) Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding. Science 323: 1718–1722. doi: 10.1126/science.1168750
    [136] Yan Y, Ochs C, Such G, et al. (2010) Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules. Adv Mater 22: 5398–5403. doi: 10.1002/adma.201003162
    [137] Zhao Y (2007) Rational design of light-controllable polymer micelles. Chem Rec 7: 286–294. doi: 10.1002/tcr.20127
    [138] Alatorre-Meda M, Alvarez-Lorenzo C, Concheiro A, et al. (2013) UV and Near-IR Triggered Release from Polymeric Micelles and Nanoparticles, in Smart Materials for Drug Delivery (Eds.: C. Alvarez-Lorenzo, A. Concheiro), RSC Publishing,Cambridge 304–348.
    [139] Hernanz D, Nunez V, Sancho A, et al. (2001) Hydroxycinnamic acids and ferulic acid dehydrodimers in barley and processed barley. J Agric Food Chem 49: 4884–4888. doi: 10.1021/jf010530u
    [140] Hoff WD, Dux P, Hard K, et al. (1994) Thiol ester-linked p-coumaric acid as a new photoactive prosthetic group in a protein with rhodopsin-like photochemistry. Biochemistry 33: 13959–13962. doi: 10.1021/bi00251a001
    [141] Wang G, Tong X, Zhao Y (2004) Preparation of Azobenzene-Containing Amphiphilic Diblock Copolymers for Light-Responsive Micellar Aggregates. Macromolecules 37: 8911–8917. doi: 10.1021/ma048416a
    [142] Shi D, Matsusaki M, Kaneko T, et al. (2008) Photo-Cross-Linking and Cleavage Induced Reversible Size Change of Bio-Based Nanoparticles. Macromolecules 41: 8167–8172. doi: 10.1021/ma800648e
    [143] Zhao Y (2012) Light-Responsive Block Copolymer Micelles. Macromolecules 45: 3647–3657. doi: 10.1021/ma300094t
    [144] Kotharangannagari VK, Sánchez-Ferrer A, Ruokolainen J, et al. (2011) Photo-Responsive Reversible Aggregation and Dissolution of Rod-Coil Polypeptide Diblock Copolymers. Macromolecules 44: 4569–4573. doi: 10.1021/ma2008145
    [145] Kumar S, Allard JF, Morris D, et al. (2012) Near-infrared light sensitive polypeptide block copolymer micelles for drug delivery. J Mater Chem 22: 7252–7257. doi: 10.1039/c2jm16380b
    [146] Li Y, Qian Y, Liu T, et al. (2012) Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles. Biomacromolecules 13: 3877–3886. doi: 10.1021/bm301425j
    [147] Liu G, Liu N, Zhou L, et al. (2015) NIR-responsive polypeptide copolymer upconversion composite nanoparticles for triggered drug release and enhanced cytotoxicity. Polym Chem 6: 4030–4039
    [148] Martinez-Cuezva A, Valero-Moya S, Alajarin M, et al. (2015) Light-responsive peptide [2]rotaxanes as gatekeepers of mechanised nanocontainers. Chem Commun 51: 14501–14504. doi: 10.1039/C5CC04365D
    [149] Stoddart JF (ed) (2001) Special issue on molecular machines. Acc Chem Res 34: 410 (2001).
    [150] Cavallini M, Biscarini F, Leon S (2003) Information Storage Using Supramolecular Surface Patterns.Science 299: 531–531. doi: 10.1126/science.1078012
    [151] Bottari G, Leigh DA, Pérez EM (2003) Chiroptical Switching in a Bistable Molecular Shuttle. J Am Chem.Soc125: 13360–13361.
    [152] Pernites RB, Santos CM, Maldonado M, et al. (2012) Tunable Protein and Bacterial Cell Adsorption on Colloidally Templated Superhydrophobic Polythiophene Films. Chem Mater 24: 870–880. doi: 10.1021/cm2007044
    [153] Gomez N, Schmidt CE (2007) Nerve growth factor-immobilized polypyrrole: Bioactive electrically conducting polymer for enhanced neurite extension. J Biomed Mater Res 81: 135–149.
    [154] Green RA, Lovell NH, Poole-Warren LA (2009) Cell attachment functionality of bioactive conducting polymers for neural interfaces. Biomaterials 30: 3637–3644. doi: 10.1016/j.biomaterials.2009.03.043
    [155] Zhong Y, Yu X, Gilbert R, et al (2001) Stabilizing electrode-host interfaces: a tissue engineering approach. J Rehabil Res Dev 38: 627–632.
    [156] Fabregat G, Ballano G, Armelin E (2013) An electroactive and biologically responsive hybrid conjugate based on chemical similarity. Polym Chem 4: 1412–1424. doi: 10.1039/C2PY20894F
    [157] Maione S, Gil AM, Fabregat G, et al. (2015) Electroactive polymer–peptide conjugates for adhesive biointerfaces. Biomater Sci 3: 1395–1405. doi: 10.1039/C5BM00160A
    [158] Jeon G, Yang SY, Byun J, et al. (2011) Electrically actuatable smart nanoporous membrane for pulsatile drug release. Nano Lett 11: 1284–1288. doi: 10.1021/nl104329y
    [159] Ge J, Neofytou E, Cahill TJ, et al. (2012) Drug release from electric-field-responsive nanoparticles. ACS Nano 6: 227–233. doi: 10.1021/nn203430m
    [160] Wu L, Wang J, Gao N, et al. (2015) Electrically pulsatile responsive drug delivery platform for treatment of Alzheimer’s disease. Nano Res 8: 2400–2414. doi: 10.1007/s12274-015-0750-x
    [161] Santos JL, Li Y, Culver HR, et al. (2014) Conducting polymer nanoparticles decorated with collagen mimetic peptides for collagen targeting. Chem Commun 50: 15045–15048.
    [162] Cheng R, Meng F, Deng C, et al. (2013) Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34: 3647–3657. doi: 10.1016/j.biomaterials.2013.01.084
    [163] Dai J, Lin SD, Cheng D, et al. (2011) Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed 50: 9404–9408. doi: 10.1002/anie.201103806
    [164] Yu S, Wu G, Gu X, et al. (2013) Magnetic and pH-sensitive nanoparticles for antitumor drug deliver. Colloids Surf B 103: 15–22. doi: 10.1016/j.colsurfb.2012.10.041
    [165] Remant BKC, Thapa B, Xu P (2012) pH and Redox Dual Responsive Nanoparticle for Nuclear Targeted Drug Delivery. Mol Pharmaceutics 9: 2719–2729.
    [166] Gupta MK, Lee SH, Crowder SW, et al. (2015) Oligoproline-derived nanocarrier for dual stimuli-responsive gene delivery. J Mater Chem 3: 7271–7280. doi: 10.1039/C5TB00988J
  • This article has been cited by:

    1. Zuolin Shen, Junjie Wei, Bifurcation Analysis in a Diffusive Mussel-Algae Model with Delay, 2019, 29, 0218-1274, 1950144, 10.1142/S021812741950144X
    2. Yuying Liu, Junjie Wei, Dynamical analysis in a diffusive predator‐prey system with a delay and strong Allee effect, 2020, 43, 0170-4214, 1590, 10.1002/mma.5987
    3. Yan Zhang, Shujing Gao, Shihua Chen, Modelling and analysis of a stochastic nonautonomous predator-prey model with impulsive effects and nonlinear functional response, 2021, 18, 1551-0018, 1485, 10.3934/mbe.2021077
    4. Yue Zhang, Xue Li, Xianghua Zhang, Guisheng Yin, Lei Chen, Stability and Hopf Bifurcation Analysis of an Epidemic Model with Time Delay, 2021, 2021, 1748-6718, 1, 10.1155/2021/1895764
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(10844) PDF downloads(1815) Cited by(7)

Article outline

Figures and Tables

Figures(19)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog